Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
CGC
Strong SellSinkerCanopy Growth Corporation · Healthcare · Canada · $475M · Avg Vol: $3M/d
COMPANY DESCRIPTION
Canopy Growth Corporation is a global leader in the cannabis and hemp-derived products market, involved in cultivation, processing, and sales of a wide range of medical and recreational cannabis products. The company leverages its extensive brand portfolio, significant cultivation infrastructure, and strategic partnerships, including with Constellation Brands, to maintain a prominent market position. As an early mover in regulated cannabis markets, it has established a broad consumer reach and continues to invest in product innovation and market expansion.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | 2026 | CAGR | TTM | 2027E | 2028E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 475.7M | 241.3M | 215.1M | 194.8M | 206.1M | -18.9% | 212.7M | 250.1M | 271.0M | 14.7% |
| EPS | -7.70 | -6.27 | -1.45 | -1.75 | -0.64 | — | -0.48 | — | — | — |
| Shares | 39.4M | 422.2M | 422.2M | 422.2M | 422.1M | +970.1% | 423.0M | — | — | — |
| Debt | 1.6B | 1.0B | 432.4M | 252.2M | 201.8M | -40.8% | 200.9M | — | — | — |
| Equity | 3.6B | 549.1M | 289.9M | 346.5M | 505.1M | -38.7% | — | — | — | — |
| Op CF | -545.8M | -403.7M | -204.1M | -120.0M | -46.2M | — | -56.8M | — | — | — |
| Inv CF | 230.8M | 313.8M | 174.9M | -34.6M | -15.5M | — | — | — | — | — |
| Fin CF | -45.5M | -14.3M | -336.7M | 107.6M | 240.7M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of CGC are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| CGC | Canopy Growth Corporation(you) | $475M | 19 | Strong Sell |
| TLRY | Tilray Brands, Inc. | $631M | 13 | Strong Sell |
| CRDL.TO | Cardiol Therapeutics Inc. | $252M | 23 | Sell |
| ACB | Aurora Cannabis Inc. | $254M | 36 | Hold |
| TSND.TO | TerrAscend Corp. | $243M | 61 | Hold |
| VM.V | Voyageur Pharmaceuticals Ltd. | $28M | 20 | Sell |
| LSL.V | LSL Pharma Group Inc. | $30M | 15 | Strong Sell |
| NVRS.CN | Noveris Health Sciences Inc. | $55M | 2 | Strong Sell |
| MLCO.CN | The More Life Company Corp. | $26M | 22 | Sell |
| LEEF.CN | Leef Brands Inc. | $58M | 41 | Hold |
Peer medians: ROE -31.6% · P/E 17.3x · Gross margin 46.2%